Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964–2003 followed up to the end of 2006

Figures & data

Figure 1. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for Hodgkin lymphoma by sex and country. Nordic cancer survival study 1964–2003.

Table I. Trends in survival for Hodgkin lymphoma by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	371	36 (31–41)	310	30 (26–36)	15	*	299	34 (28–40)	745	38 (34–43)
1969–1973	410	53 (49–58)	371	49 (44–54)	22	*	313	54 (48–60)	823	51 (47–55)
1974–1978	399	59 (55–64)	323	54 (49–60)	20	*	319	56 (52–62)	677	56 (53–60)
1979–1983	383	64 (59–69)	382	62 (58–67)	14	*	294	65 (61–71)	546	66 (63–70)
1984–1988	388	68 (64–73)	308	71 (67–76)	15	*	238	70 (65–75)	551	71 (68–75)
1989–1993	394	75 (70–80)	330	71 (67–75)	18	*	268	76 (71–81)	487	78 (75–82)
1994–1998	359	75 (71–79)	374	80 (76–85)	19	*	264	82 (78–87)	490	80 (77–83)
1999–2003	357	80 (77–84)	362	85 (81–88)	29	*	315	84 (81–88)	454	84 (81–86)
Women
1964–1968	249	45 (40–51)	226	44 (39–51)	7	*	227	50 (43–57)	507	47 (42–52)
1969–1973	298	56 (51–62)	235	54 (48–60)	12	*	210	61 (55–68)	511	57 (52–62)
1974–1978	247	63 (58–69)	254	66 (61–71)	11	*	215	65 (60–70)	455	63 (59–68)
1979–1983	258	69 (64–75)	252	70 (65–76)	7	*	199	70 (65–75)	415	70 (66–74)
1984–1988	219	72 (66–77)	262	73 (68–78)	4	*	170	75 (69–81)	397	75 (71–79)
1989–1993	246	73 (68–79)	261	80 (76–86)	8	*	165	78 (72–85)	386	78 (74–82)
1994–1998	241	79 (74–85)	284	83 (79–87)	10	*	180	85 (79–91)	362	82 (79–86)
1999–2003	261	84 (81–88)	291	84 (81–88)	15	*	232	85 (82–89)	405	84 (81–87)

*Too few patients to calculate survival, see ref. [12].

Figure 2. Trends in age-standardised (ICSS) excess death rates per 100 person years for Hodgkin lymphoma by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003. No Icelandic curves. Too few patients to calculate rates for Iceland.

Table II. Trends in 5-year age-specific relative survival in percent after Hodgkin lymphoma by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–29	30–39	40–49	50–69	70–89	90+	0–29	30–39	40–49	50–69	70–89	90+
Denmark
1964–1968	54	41	37	24	5	*	72	51	44	23	8	*
1969–1973	75	73	46	30	18	*	82	63	46	43	20	*
1974–1978	79	77	61	40	16	*	80	94	70	40	13	*
1979–1983	75	76	71	56	26	*	89	71	97	51	28	*
1984–1988	87	83	79	57	15	*	91	88	79	57	21	*
1989–1993	91	84	77	64	40	*	85	86	94	60	31	*
1994–1998	92	90	91	69	12	*	90	94	86	62	49	*
1999–2003	95	94	90	73	34	*	94	94	91	83	48	*
Finland
1964–1968	47	35	32	18	7	*	69	65	31	17	14	*
1969–1973	73	54	52	35	9	*	80	60	76	28	7	*
1974–1978	75	66	61	32	21	*	86	86	65	39	31	*
1979–1983	87	72	59	42	25	*	91	88	62	59	26	*
1984–1988	94	82	70	64	18	*	91	88	77	59	30	*
1989–1993	88	90	81	62	10	*	97	94	87	63	45	*
1994–1998	91	88	95	76	41	*	96	95	98	73	39	*
1999–2003	94	92	96	78	53	*	97	97	99	71	46	*
Iceland
1964–1968	62	*	*	12	*	*	*	*	*	*	*	*
1969–1973	62	*	*	12	*	*	*	*	*	*	*	*
1974–1978	92	*	*	*	*	*	*	*	*	*	*	*
1979–1983	92	*	*	*	*	*	*	*	*	*	*	*
1984–1988	89	*	*	105	*	*	*	*	*	*	*	*
1989–1993	89	*	*	105	*	*	*	*	*	*	*	*
1994–1998	97	100	101	86	*	*	*	*	*	*	*	*
1999–2003	97	100	101	86	*	*	*	*	*	*	*	*
Norway
1964–1968	41	48	37	27	4	*	71	72	51	22	10	*
1969–1973	75	55	55	40	27	*	83	78	73	34	17	*
1974–1978	84	76	53	31	8	*	86	87	91	31	12	*
1979–1983	83	89	68	48	16	*	89	97	76	51	14	*
1984–1988	99	78	77	47	21	*	92	85	91	68	20	*
1989–1993	92	82	84	74	27	*	91	90	93	67	40	*
1994–1998	93	93	96	86	28	*	94	98	94	81	44	*
1999–2003	97	95	93	83	37	*	95	97	93	88	38	51
Sweden
1964–1968	56	47	39	22	10	*	70	62	39	26	11	*
1969–1973	78	63	41	32	12	*	84	72	51	32	18	0
1974–1978	80	70	61	35	13	*	87	73	70	42	23	*
1979–1983	86	82	71	43	32	*	87	89	78	50	25	*
1984–1988	94	88	83	44	26	*	95	93	67	62	32	*
1989–1993	93	90	87	72	30	*	93	92	84	69	33	52
1994–1998	95	95	93	65	37	*	96	93	101	73	33	*
1999–2003	94	98	94	76	43	*	96	93	99	76	45	*

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [12].

Figure 3. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for non-Hodgkin lymphoma by sex and country. Nordic cancer survival study 1964–2003.

Table III. Trends in survival for non-Hodgkin lymphoma by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	664	24 (20–29)	553	24 (18–33)	16	29 (16–53)	568	23 (19–28)	1 166	23 (20–26)
1969–1973	836	20 (17–23)	630	24 (19–29)	21	29 (16–53)	589	27 (23–32)	1 431	28 (25–31)
1974–1978	979	28 (24–31)	789	29 (25–34)	24	52 (28–97)	783	36 (32–40)	1 512	32 (29–35)
1979–1983	1 191	34 (31–38)	997	37 (32–41)	28	46 (27–77)	893	40 (36–44)	1 633	41 (38–44)
1984–1988	1 447	38 (35–42)	1 229	38 (35–42)	48	30 (21–44)	1 216	44 (41–48)	2 308	47 (44–49)
1989–1993	1 724	43 (40–46)	1 659	42 (39–45)	67	42 (30–58)	1 445	43 (40–46)	3 188	49 (47–51)
1994–1998	1 914	43 (41–46)	2 013	47 (45–50)	93	51 (40–66)	1 677	47 (44–50)	3 380	50 (48–52)
1999–2003	2 014	50 (48–53)	2 260	53 (51–55)	101	56 (47–67)	1 748	51 (48–53)	3 703	54 (53–56)
Women
1964–1968	565	25 (21–28)	425	20 (16–25)	8	20 (10–39)	462	28 (24–34)	903	28 (25–31)
1969–1973	681	26 (22–30)	509	29 (25–35)	12	20 (10–39)	509	31 (27–35)	1 154	33 (30–36)
1974–1978	805	32 (28–35)	718	35 (32–40)	20	45 (31–65)	631	39 (35–43)	1 163	39 (36–42)
1979–1983	997	40 (37–43)	1 022	40 (37–44)	27	45 (31–65)	810	49 (45–53)	1 211	43 (40–46)
1984–1988	1 325	45 (42–48)	1 375	44 (41–47)	26	54 (32–88)	1 086	50 (47–54)	1 912	49 (47–52)
1989–1993	1 566	50 (47–53)	1 774	49 (46–51)	40	60 (45–81)	1 303	54 (51–57)	2 565	54 (52–56)
1994–1998	1 681	52 (50–55)	2 078	51 (49–54)	66	54 (43–68)	1 437	52 (50–55)	2 925	57 (55–59)
1999–2003	1 797	55 (53–57)	2 234	58 (56–60)	74	57 (48–68)	1 643	57 (55–59)	3 111	60 (58–61)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

Table IV. Trends in 5-year age-specific relative survival in percent after non-Hodgkin lymphoma by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	34	31	29	16	15	0	37	37	32	18	0	0
1969–1973	27	26	24	15	8	0	37	35	25	22	15	0
1974–1978	41	35	30	25	10	0	50	43	36	22	14	0
1979–1983	53	50	38	26	12	0	59	59	45	29	15	37
1984–1988	57	50	37	32	24	50	75	61	49	33	20	29
1989–1993	61	55	49	35	21	31	74	63	54	38	28	24
1994–1998	60	58	46	38	20	0	77	66	58	42	27	13
1999–2003	69	64	55	41	31	0	78	73	61	44	28	13
Finland
1964–1968	28	25	21	11	51	*	33	29	21	13	9	*
1969–1973	43	25	30	16	10	*	39	43	25	25	21	*
1974–1978	49	40	27	29	7	*	56	41	41	28	18	0
1979–1983	53	43	33	33	29	0	63	52	44	30	21	*
1984–1988	63	50	41	30	16	0	68	61	47	34	19	30
1989–1993	71	56	45	30	18	0	75	64	53	36	26	26
1994–1998	75	57	49	40	25	0	79	71	55	39	23	18
1999–2003	77	67	57	42	31	3	83	75	63	48	27	14
Iceland
1964–1968	46	46	24	20	20	*	51	51	18	*	*	*
1969–1973	46	46	24	20	20	*	51	51	18	*	*	*
1974–1978	46	46	51	58	58	*	71	71	41	30	30	*
1979–1983	58	58	*	66	66	*	71	71	41	30	30	*
1984–1988	70	70	37	0	0	*	59	59	43	56	56	*
1989–1993	56	56	55	25	25	*	62	62	70	52	52	*
1994–1998	56	56	52	48	48	*	91	91	31	44	44	*
1999–2003	78	78	58	40	40	*	91	91	47	41	41	*
Norway
1964–1968	39	40	17	19	11	0	48	37	33	19	14	*
1969–1973	46	38	30	12	23	*	49	46	34	23	8	*
1974–1978	53	49	36	28	20	*	49	49	50	30	16	0
1979–1983	57	51	39	33	28	*	63	62	49	39	41	0
1984–1988	60	52	47	36	35	0	62	74	47	43	34	0
1989–1993	63	64	41	36	19	0	73	62	63	46	28	72
1994–1998	65	61	51	41	23	53	71	69	55	46	27	22
1999–2003	75	68	53	43	23	23	80	68	64	50	28	24
Sweden
1964–1968	34	30	23	19	16	81	41	35	32	22	12	0
1969–1973	43	42	25	20	23	0	46	40	35	28	21	0
1974–1978	49	43	34	26	14	120	56	52	43	30	22	26
1979–1983	65	53	42	34	20	0	69	59	45	33	17	0
1984–1988	72	61	47	35	32	0	71	63	49	43	29	21
1989–1993	68	59	51	43	29	15	76	69	57	46	29	0
1994–1998	75	63	52	42	28	15	80	72	61	49	28	18
1999–2003	77	68	57	46	33	46	82	78	63	49	35	20

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [12].

Figure 4. Trends in age-standardised (ICSS) excess death rates per 100 person years for non-Hodgkin lymphoma by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003.

Figure 5. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for multiple myeloma by sex and country. Nordic cancer survival study 1964–2003.

Figure 6. Trends in age-standardised (ICSS) excess death rates per 100 person years for multiple myeloma by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003.

Table V. Trends in survival for multiple myeloma by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	376	16 (12–20)	245	15 (10–22)	8	*	420	18 (14–23)	516	19 (15–23)
1969–1973	438	13 (10–17)	308	20 (16–25)	8	*	511	25 (21–30)	699	22 (19–26)
1974–1978	493	15 (12–19)	385	32 (26–38)	22	41 (27–60)	674	30 (26–34)	817	29 (25–33)
1979–1983	597	17 (14–21)	435	32 (27–38)	34	41 (27–60)	743	28 (25–32)	1 081	31 (28–34)
1984–1988	625	22 (18–26)	594	33 (29–38)	33	31 (20–49)	742	30 (26–34)	1 331	32 (29–35)
1989–1993	664	21 (18–25)	570	28 (24–32)	25	31 (20–49)	707	33 (29–37)	1 437	32 (30–35)
1994–1998	703	23 (20–27)	593	31 (27–35)	36	29 (19–42)	797	33 (30–37)	1 443	36 (33–39)
1999–2003	759	28 (25–31)	663	34 (31–37)	25	29 (19–42)	798	36 (33–39)	1 475	37 (35–39)
Women
1964–1968	296	14 (10–19)	255	14 (10–21)	5	*	382	17 (13–22)	392	18 (14–23)
1969–1973	355	14 (10–18)	413	23 (18–29)	9	*	429	25 (20–31)	611	23 (19–27)
1974–1978	415	20 (16–25)	453	29 (25–34)	14	19 (9–39)	584	29 (25–34)	721	33 (29–37)
1979–1983	522	16 (13–21)	632	33 (29–38)	24	19 (9–39)	615	35 (31–40)	953	32 (29–36)
1984–1988	577	23 (19–27)	703	35 (31–40)	32	47 (34–65)	645	28 (24–33)	1 116	35 (32–39)
1989–1993	616	25 (22–30)	649	30 (26–34)	25	47 (34–65)	633	31 (27–36)	1 160	35 (32–38)
1994–1998	589	29 (25–33)	824	32 (29–36)	32	30 (17–54)	642	35 (31–40)	1 218	37 (34–40)
1999–2003	623	33 (30–36)	703	33 (31–36)	30	29 (18–48)	758	38 (35–42)	1 300	41 (38–43)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [12].

Table VI. Trends in 5-year age-specific relative survival in percent after multiple myeloma by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	29	24	18	6	9	*	6	25	18	11	5	*
1969–1973	24	12	13	12	4	0	28	25	15	4	4	*
1974–1978	12	21	18	11	13	*	36	33	24	13	0	*
1979–1983	29	27	16	13	8	*	34	24	16	10	8	*
1984–1988	36	29	19	17	15	*	41	38	20	16	9	*
1989–1993	32	27	20	16	17	0	33	31	25	26	15	0
1994–1998	49	43	23	11	6	*	58	41	28	20	11	0
1999–2003	46	47	29	17	8	0	59	49	36	21	10	0
Finland
1964–1968	24	11	19	17	0	*	22	25	11	9	11	*
1969–1973	39	36	21	11	0	*	24	25	24	20	24	*
1974–1978	51	43	33	22	20	*	51	27	37	25	7	*
1979–1983	42	40	46	18	17	0	59	43	36	25	12	0
1984–1988	51	49	35	24	13	0	61	39	40	25	19	0
1989–1993	62	41	26	19	5	0	52	46	35	17	6	0
1994–1998	60	59	31	13	9	0	65	48	33	23	6	0
1999–2003	68	62	35	17	8	0	78	47	35	20	5	8
Iceland
1964–1968	31	31	31	*	*	*	24	24	24	*	*	*
1969–1973	31	31	31	*	*	*	24	24	24	*	*	*
1974–1978	33	33	33	50	52	*	19	19	19	10	34	*
1979–1983	33	33	33	50	52	*	19	19	19	10	34	*
1984–1988	39	39	39	18	29	*	49	49	49	43	51	*
1989–1993	39	39	39	18	29	*	49	49	49	43	51	*
1994–1998	37	37	37	20	12	*	39	39	39	29	*	*
1999–2003	37	37	37	20	12	*	25	25	25	38	29	*
Norway
1964–1968	26	21	18	14	14	*	28	21	20	12	9	*
1969–1973	47	24	25	22	14	*	36	28	27	18	22	0
1974–1978	62	32	28	23	17	0	53	38	31	20	16	0
1979–1983	64	30	30	22	8	0	43	58	33	29	18	0
1984–1988	49	36	30	27	12	0	28	34	28	35	10	0
1989–1993	60	44	34	21	17	0	45	46	27	28	19	0
1994–1998	58	51	37	22	9	0	58	43	35	28	23	0
1999–2003	61	56	40	23	14	60	73	56	36	28	15	1
Sweden
1964–1968	33	30	22	11	4	*	28	26	19	9	14	*
1969–1973	37	31	23	17	11	0	39	34	23	16	8	*
1974–1978	50	29	34	23	13	*	64	37	35	24	16	0
1979–1983	55	41	29	26	9	69	55	35	34	26	18	0
1984–1988	49	36	35	27	17	0	52	44	38	29	18	0
1989–1993	51	46	35	24	12	0	46	52	36	29	16	0
1994–1998	62	54	36	25	14	52	58	62	37	25	17	0
1999–2003	72	54	37	25	12	1	73	61	40	27	18	18

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [12].

Figure 7. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for acute leukaemia by sex and country. Nordic cancer survival study 1964–2003.

Figure 8. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for other leukaemia by sex and country. Nordic cancer survival study 1964–2003.

Table VII. Trends in survival for acute leukaemia by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	429	3 (1–5)	377	2 (1–4)	19	*	457	1 (1–4)	404	7 (5–12)
1969–1973	594	8 (5–11)	387	3 (2–5)	24	*	479	7 (5–10)	581	9 (6–13)
1974–1978	606	14 (11–18)	445	9 (7–12)	20	*	501	17 (13–21)	623	14 (11–18)
1979–1983	713	17 (14–20)	506	19 (15–23)	34	*	545	20 (17–25)	806	17 (15–20)
1984–1988	736	28 (24–32)	526	30 (26–34)	24	*	533	30 (25–36)	960	31 (28–35)
1989–1993	752	31 (27–35)	498	37 (32–42)	30	*	442	36 (31–42)	997	33 (30–37)
1994–1998	669	35 (31–40)	563	39 (35–44)	35	*	442	34 (29–40)	970	41 (37–45)
1999–2003	809	41 (38–45)	586	42 (38–46)	28	*	487	38 (33–43)	1 018	43 (40–46)
Women
1964–1968	337	1 (0–3)	378	3 (1–6)	14	*	353	3 (1–6)	318	8 (5–13)
1969–1973	488	6 (4–9)	361	6 (4–10)	18	*	390	9 (6–12)	466	12 (8–16)
1974–1978	551	15 (12–19)	433	14 (11–18)	20	10 (4–22)	470	13 (10–17)	582	18 (15–22)
1979–1983	623	21 (17–25)	513	24 (20–28)	21	10 (4–22)	441	21 (17–25)	771	25 (21–28)
1984–1988	676	27 (24–32)	522	31 (26–35)	32	51 (38–68)	434	28 (23–34)	881	29 (26–32)
1989–1993	596	29 (25–33)	527	42 (37–47)	26	51 (38–68)	383	33 (28–39)	866	36 (32–39)
1994–1998	666	36 (31–41)	568	47 (42–52)	26	40 (30–53)	431	42 (37–47)	964	41 (38–45)
1999–2003	674	42 (38–46)	610	49 (45–53)	30	40 (30–53)	417	44 (40–50)	922	46 (43–49)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [12].

Table VIII. Trends in survival for other leukaemia by sex and country. Number of tumours (N) included and the 5–year age–standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	752	18 (15–21)	479	25 (20–31)	9	14 (5–44)	465	18 (15–23)	834	18 (15–22)
1969–1973	765	24 (20–28)	580	25 (21–29)	16	14 (5–44)	535	21 (17–25)	1 029	22 (19–25)
1974–1978	898	25 (22–29)	587	37 (33–42)	28	32 (20–52)	584	30 (26–35)	1 191	30 (27–33)
1979–1983	1 028	33 (30–37)	659	43 (38–48)	23	32 (20–52)	598	36 (32–41)	1 525	38 (36–41)
1984–1988	1 134	41 (38–45)	731	45 (41–50)	39	55 (38–80)	565	38 (33–43)	1 598	46 (43–49)
1989–1993	1 089	49 (46–53)	649	52 (47–56)	28	64 (46–88)	659	46 (42–51)	1 489	54 (51–57)
1994–1998	1 220	56 (53–60)	708	54 (50–58)	37	66 (49–90)	787	53 (49–57)	1 780	62 (59–65)
1999–2003	1 278	63 (60–65)	746	55 (52–58)	45	71 (59–85)	929	58 (55–61)	1 886	68 (66–70)
Women
1964–1968	433	25 (21–30)	444	25 (21–30)	10	18 (7–46)	376	21 (17–26)	544	19 (16–24)
1969–1973	468	30 (26–35)	502	36 (31–42)	14	18 (7–46)	337	30 (25–37)	694	25 (22–29)
1974–1978	601	31 (27–36)	520	42 (38–47)	13	42 (25–71)	377	36 (31–42)	770	38 (34–42)
1979–1983	689	43 (39–48)	616	49 (45–54)	12	42 (25–71)	424	39 (34–45)	989	41 (37–44)
1984–1988	735	47 (43–52)	603	53 (49–58)	18	52 (39–70)	417	39 (34–45)	986	50 (47–54)
1989–1993	829	57 (53–61)	546	53 (48–58)	27	52 (39–70)	500	53 (48–58)	987	59 (56–63)
1994–1998	870	63 (59–67)	600	54 (49–59)	29	59 (42–83)	615	62 (57–67)	1 125	66 (63–69)
1999–2003	915	68 (65–71)	558	60 (56–64)	28	68 (54–86)	662	64 (61–68)	1 244	70 (68–73)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

Table IX. Trends in 5–year age–specific relative survival in percent after acute leukaemia by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–29	30–49	50–69	70–79	80–89	90+	0–29	30–49	50–69	70–79	80–89	90+
Denmark
1964–1968	4	3	1	0	0	*	2	0	0	3	0	*
1969–1973	14	7	3	4	0	*	17	2	1	0	0	*
1974–1978	24	17	3	2	0	*	37	6	8	2	0	*
1979–1983	38	12	4	1	0	0	45	17	5	3	0	0
1984–1988	53	28	8	1	0	0	60	20	9	2	0	0
1989–1993	63	24	12	4	0	0	64	17	14	3	2	0
1994–1998	68	31	16	1	0	0	70	33	13	1	2	0
1999–2003	72	43	19	4	0	0	77	43	16	3	1	0
Finland
1964–1968	2	2	2	0	0	*	3	5	0	0	0	*
1969–1973	8	0	3	0	0	*	11	2	7	0	13	*
1974–1978	25	2	4	0	0	*	39	5	1	3	0	*
1979–1983	41	14	6	1	0	*	58	12	5	4	0	*
1984–1988	57	28	12	3	5	*	68	20	12	2	0	*
1989–1993	72	33	16	0	0	*	72	44	21	6	0	*
1994–1998	69	44	10	4	0	*	80	50	23	2	0	0
1999–2003	74	44	17	5	0	*	81	53	27	4	0	0
Iceland
1964–1968	13	*	12	*	*	*	8	*	*	*	*	*
1969–1973	13	*	12	*	*	*	8	*	*	*	*	*
1974–1978	35	*	10	*	*	*	31	0	*	*	*	*
1979–1983	35	*	10	*	*	*	31	0	*	*	*	*
1984–1988	56	13	9	*	*	*	83	67	11	*	0	*
1989–1993	56	13	9	*	*	*	83	67	11	*	0	*
1994–1998	89	*	17	*	*	*	73	51	1	*	*	*
1999–2003	89	*	17	*	*	*	73	51	1	*	*	*
Norway
1964–1968	2	2	1	0	0	*	6	3	1	0	0	*
1969–1973	15	6	1	0	0	0	22	4	3	0	0	*
1974–1978	33	13	8	1	0	*	38	4	1	1	0	0
1979–1983	48	14	4	0	0	0	58	6	4	4	3	*
1984–1988	58	30	10	1	0	*	61	21	11	0	0	*
1989–1993	70	34	10	8	0	*	75	25	7	1	0	0
1994–1998	69	32	9	0	0	*	75	42	19	3	0	0
1999–2003	74	36	11	0	0	*	79	48	17	4	0	0
Sweden
1964–1968	3	8	13	11	6	*	4	9	14	9	6	0
1969–1973	7	8	13	15	4	*	16	8	11	11	13	69
1974–1978	31	8	8	2	0	*	38	11	9	5	7	58
1979–1983	44	7	4	4	0	0	53	19	7	1	2	0
1984–1988	63	26	12	2	0	0	67	15	13	5	0	0
1989–1993	68	27	13	6	0	0	71	29	17	6	1	0
1994–1998	78	38	16	4	2	0	78	39	16	5	1	0
1999–2003	77	45	17	5	2	0	80	47	24	4	1	0

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [12].

Table X. Trends in 5–year age–specific relative survival in percent after other leukaemia by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	25	36	18	13	2	0	32	30	33	20	8	0
1969–1973	26	32	30	18	13	*	27	44	43	22	8	*
1974–1978	32	43	30	18	7	70	26	37	34	32	23	40
1979–1983	42	52	39	26	6	0	51	47	58	39	15	0
1984–1988	53	59	39	36	24	0	64	60	57	40	17	0
1989–1993	72	66	55	39	24	25	54	70	62	54	42	16
1994–1998	72	72	60	49	33	54	75	77	67	58	39	12
1999–2003	78	82	70	53	33	19	88	83	73	59	40	22
Finland
1964–1968	19	36	30	23	11	*	29	28	35	20	10	*
1969–1973	21	43	32	22	0	*	21	47	43	30	36	*
1974–1978	40	51	46	33	11	0	49	50	52	38	19	*
1979–1983	37	52	48	48	17	0	43	55	59	47	35	0
1984–1988	51	56	57	40	17	96	52	68	65	47	28	30
1989–1993	65	71	63	42	17	0	62	66	55	55	24	0
1994–1998	69	71	60	48	22	0	71	72	59	46	26	18
1999–2003	80	74	65	40	22	0	81	74	72	51	22	6
Iceland
1964–1968	13	13	13	23	0	*	21	21	21	22	*	*
1969–1973	13	13	13	23	0	*	21	21	21	22	*	*
1974–1978	35	35	35	26	32	*	52	52	52	20	47	*
1979–1983	35	35	35	26	32	*	52	52	52	20	47	*
1984–1988	51	51	51	45	90	*	60	60	60	64	0	*
1989–1993	82	82	82	34	51	*	60	60	60	64	0	*
1994–1998	74	74	74	65	40	*	74	74	74	38	46	*
1999–2003	83	83	83	69	33	*	73	73	73	62	60	*
Norway
1964–1968	19	25	26	12	9	*	21	36	16	18	16	*
1969–1973	24	28	26	16	9	0	29	39	34	28	20	*
1974–1978	35	47	31	29	10	48	46	50	43	28	17	0
1979–1983	39	60	44	22	17	0	34	54	49	37	11	0
1984–1988	48	58	44	28	13	0	39	47	54	32	18	0
1989–1993	68	65	50	37	19	0	58	68	64	46	26	42
1994–1998	59	75	61	42	29	39	63	77	70	58	36	0
1999–2003	75	75	66	48	33	18	68	74	78	56	41	18
Sweden
1964–1968	15	26	22	16	11	0	14	31	25	15	11	0
1969–1973	16	34	27	18	9	0	13	38	31	21	19	0
1974–1978	28	40	41	26	10	0	35	60	44	29	20	0
1979–1983	49	50	43	32	21	0	40	51	48	39	22	51
1984–1988	53	64	51	38	27	0	49	55	59	49	33	14
1989–1993	67	67	61	47	29	32	65	74	63	58	32	27
1994–1998	75	73	66	56	42	20	76	75	72	64	42	24
1999–2003	79	81	72	62	47	9	80	82	78	67	43	27

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [12].

Figure 9. Trends in age-standardised (ICSS) excess death rates per 100 person years for acute leukaemia by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003.

Figure 10. Trends in age-standardised (ICSS) excess death rates per 100 person years for other leukaemia by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003.

Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up the end of 2006. Material and methods. Acta Oncol; 2010.

 Google Scholar